NLR levels at diagnosis | NLR levels at 1st year | p-values | PLR levels at diagnosis | PLR levels at first year | p-values | |
---|---|---|---|---|---|---|
Non-survived (pirfenidone) | 2.22 (1.78) | 2.55 (1.89) | 0.02 | 105.7 (69.9) | 134.2 (93.2) | 0.01 |
Survived (pirfenidone) | 2.55 (1.45) | 2.80 (1.38) | 0.41 | 117.8 (59.8) | 128.7 (59.5) | 0.3 |
Non-survived (nintedanib) | 2.56 (2.08) | 2.82 (2.0) | 0.57 | 136.6 (74.6) | 137.1 (64.5) | 0.88 |
Survived (nintedanib) | 2.11 (1.27) | 2.11 (0.89) | 0.53 | 121.1 (46.8) | 105.9 (36.8) | 0.04 |